Eikon Therapeutics

📍 Hayward, United States🗓 Founded 2019👥 389 employees💰 Last funded Dec 2023
Biotechnology Research🌐 eikontx.com
Website LinkedIn
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the interface of biology, engineering and chemistry to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells. By directly measuring the effects of chemical compounds on the behavior of protein molecules in a live cellular environment, Eikon’s landmark assays facilitate the highly sensitive identification of compound-protein interactions that could not be identified through traditional assays, thereby unlocking otherwise intractable classes of proteins as drug targets. Furthermore, the ability to directly visualize protein mechanisms in disease coupled with the extraordinarily high-powered high-content data sets generated by Eikon’s drug-screening technology enable an unprecedented opportunity to quantitatively explore novel biology in the living cell. These insights facilitate creation and application of data-driven hypotheses to the discovery of life-saving therapies. Eikon is seeking adventurous, passionate and creative team members eager to apply their talents to empower interdisciplinary scientific exploration, inaugurate a radical drug-discovery paradigm, and ultimately create novel medicines. To learn more about open positions, please visit: https://www.eikontx.com/join-us/#open-positions
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2019
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
3
Hong Kong SAR
1
Investor activity2019–2023 · investors recorded per year
201922021120231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Eikon Therapeutics?
Eikon Therapeutics has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Eikon Therapeutics last raise funding?
The most recent investment in Eikon Therapeutics recorded on gritt.io was in December 2023.
When was Eikon Therapeutics founded?
Eikon Therapeutics was founded in 2019.
What industry is Eikon Therapeutics in?
Eikon Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Eikon Therapeutics based?
Eikon Therapeutics is headquartered in Hayward, United States.